Targeting ferroptosis in breast cancer

Zhaoqing Li1,2,3, Lini Chen1,3, Cong Chen1,3

  • 1Department of Surgical Oncology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, 310000, Zhejiang, China.

Biomarker Research
|December 9, 2020
PubMed
Summary

Ferroptosis, a cell death type driven by lipid ROS, is a promising cancer therapy target. This review examines ferroptosis in breast cancer, its regulators, and subtype-specific sensitivities to guide future biomarker and treatment development.